4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-016880
Chief Business Officer sold 6,944 shares at $63.44 ($440,531)
- Chief Business Officer acquired 6,944 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parrish Jay Chief Business Officer | 2021-03-01 | Option exercise | +4,630 | $1.49 | $6,876 | 13,890 | D |
| Parrish Jay Chief Business Officer | 2021-03-01 | Option exercise | +2,314 | $1.58 | $3,645 | 16,204 | D |
| Parrish Jay Chief Business Officer | 2021-03-01 | Sale | −6,944 | $63.44 | $440,531 | 9,260 | D |
| Derivatives | |||||||
| Parrish Jay Chief Business Officer | 2021-03-01 | Option exercise · Stock Option (Right to Buy) | −4,630 | 9,259 | D | ||
| Parrish Jay Chief Business Officer | 2021-03-01 | Option exercise · Stock Option (Right to Buy) | −2,314 | 39,352 | D | ||
| Open-market sales · 6,944 sh · avg $63.44 · $440,531 | |||||||
Loading xslF345X03/doc4.xml…